Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,219.7
6.0 (0.19%)

 

  • STI Straits Times Index
    3,219.7
    6.0 (0.19%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,663.7
    -
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,071.6
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,101.5
    -
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,618.2
    9.3 (0.04%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,501.8
    -
    Index delayed 10 minutes
  • KOR KOSPI
    2,189.2
    4.3 (0.20%)
    Index delayed 20 minutes
  • XAO XAO
    6,303.4
    49.9 (0.80%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2.8M
  • Value: 33.3M
  • Rise: -
  • Fall: -
  • Unch: 846

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
AEM1.240+0.050
Genting Sing1.050+0.010
Kep Infra Tr0.470-
Rex Intl0.083+0.001
Ascendas Reit2.860-
SingTel2.980+0.010
Golden Agri-Res0.275-
ThaiBev0.835-
Frasers L&I Tr1.160-
Dyna-Mac0.109+0.003

World Indices

World Indices
Name Last Change
Nasdaq 7,839.0 +110.0
HSI 29,071.6
HSCEI 11,544.1
Jakarta 6,501.8
Nikkei 225 21,609.8 +0.9
SSE Comp 3,101.5
Shanghai A 3,248.4
Shanghai B 307.6
ShenZhen A 1,775.3
ShenZhen B 1,034.8
Taiwan W 10,609.5
PSE Comp 0.0
KOSPI 2,188.7 +3.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Biolidics BIOLIDICS LIMITED
Quotes 10 Minutes Delayed. Updated at 22 Mar 2019 08:30
Last (SGD): 0.250 Change: - High: - Remarks: -
Change (%): - Low: -
Open - Yesterday's Close 0.250
Buy Price 0.250 Sell Price 0.270
Buy Volume ('000) 10.0 Sell Volume ('000) 10.0
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.02578 Trailing EPS (SGD) e -0.02578 NAV (SGD) b 0.0518
PE a - Trailing PE f - Price / NAV b 4.8263
Dividend (SGD) d - Cash In Hand (SGD) g 0.0474 Issued & Paid-up Shares c 242,500,000
Dividend Yield (%) d - Price / Cash In Hand g 5.274 Treasury Shares h -
Beta - 75 Daysi 1.411 R-Squared - 75 Days(%)i 3.65 Market Cap (M) 60.625
Beta - 500 Daysi 1.362 R-Squared - 500 Days (%)i 3.76 Enterprise Value (M) 49.126
Piotroski F Score - Exchange Code 8YY Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 6-Month VWAP n.a. Free Float (%) 99.7
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Service - Medical Specialties
Category Classification Medical & Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 05 Mar 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Biolidics SGX 60.625 - - 4.8263 -
Industry Medical & Biotechnology SGX 1,054.126 23.565 23.435 1.4397 1.792
Medical Specialties SGX 653.445 27.700 27.717 3.6823 1.865
Local Peer Top Glove SGX 3,764.056 26.068 25.845 4.6475 1.931
Local Peer UG Healthcare SGX 36.340 8.382 9.688 0.8672 1.238
Local Peer Yunnan Energy SGX 26.442 14.815 25.548 0.2380 -
Local Peer Medtecs Intl SGX 17.032 13.656 13.658 0.2003 -
Local Peer Annica SGX 16.175 - - 3.3333 -
Global Peer ABBOTT LABORATORIES NYSE 140,622.988 59.763 59.763 4.6070 1.448
Global Peer MEDTRONIC PLC NYSE 123,519.915 39.794 25.111 2.4789 2.105
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 108,150.034 36.811 36.811 3.9205 0.271
Global Peer DANAHER CORP NYSE 94,451.753 35.630 35.630 3.3476 0.475
Global Peer STRYKER CORP NYSE 73,787.670 20.768 20.768 6.2905 0.979
Global Peer INTUITIVE SURGICAL INC NASDAQ 66,676.351 59.116 59.115 9.9833 -
Global Peer BECTON DICKINSON & CO NYSE 66,033.441 415.304 73.780 3.0854 1.227
Global Peer BOSTON SCIENTIFIC CORP NYSE 52,874.374 31.642 31.642 6.0594 -
Global Peer BAXTER INTERNATIONAL INC NYSE 40,208.606 24.759 24.759 5.1589 0.931
Global Peer EDWARDS LIFESCIENCES CORP NYSE 39,922.237 55.279 55.279 12.7125 -
Other Global Peers ZIMMER BIOMET HOLDINGS INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), WATERS CORP (NYSE), ABIOMED INC (NASDAQ), COOPER COS INC (NYSE), RESMED INC (NYSE), TELEFLEX INC (NYSE), HOLOGIC INC (NASDAQ), DEXCOM INC (NASDAQ), VARIAN MEDICAL SYSTEMS INC (NYSE), DENTSPLY SIRONA INC (NASDAQ), PERKINELMER INC (NYSE), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), QIAGEN NV (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COCHLEAR LTD (ASX), MASIMO CORPORATION (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), BRUKER CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), INSULET CORPORATION (NASDAQ), PENUMBRA INC (NYSE), ICU MEDICAL INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NOVOCURE LTD (NASDAQ), GLOBUS MED INC (NYSE), LIVANOVA PLC (NASDAQ), WEIGAO GROUP (HKEx), HAEMONETICS CORP (NYSE), TANDEM DIABETES CARE INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), HARTA (Bursa), NEOGEN CORP (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), NUVASIVE INC (NASDAQ), TOPGLOV (Bursa), GLAUKOS CORPORATION (NYSE), CANTEL MEDICAL CORP (NYSE), QUIDEL CORP (NASDAQ), BIOTELEMETRY INC (NASDAQ), CONMED CORP (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), EBOS GROUP (ASX), INOGEN INC (NASDAQ), AVANOS MEDICAL INC (NYSE), NEVRO CORP (NYSE), STAAR SURGICAL CO (NASDAQ), MICROPORT (HKEx), CAREDX INC (NASDAQ), ATRION CORP (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), VAREX IMAGING CORPORATION (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ATRICURE INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), CRYOLIFE INC (NYSE), ORTHOFIX MEDICAL INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), NANOSONICS LIMITED (ASX), NATUS MEDICAL INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), LIFETECH SCI (HKEx), MESA LABORATORIES INC (NASDAQ), CERUS CORP (NASDAQ), ANGIODYNAMICS INC (NASDAQ), VERICEL CORP (NASDAQ), CIRC (HKEx), AXOGEN INC (NASDAQ), VIEWRAY INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), HESKA CORP (NASDAQ), AK MEDICAL (HKEx), SURMODICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), QUOTIENT LTD (NASDAQ), YESTAR HEALTH (HKEx), ANTARES PHARMA INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), SUPERMX (Bursa), SI BONE INC (NASDAQ), CORINDUS VASCULAR ROBOTICS INC (NYSE American), ACCURAY INCORPORATED (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), VAPOTHERM INC (NYSE), UTAH MEDICAL PRODUCTS (NASDAQ), NEURONETICS INC (NASDAQ), INVACARE CORP (NYSE), GOLDEN MEDITECH (HKEx), IRADIMED CORP (NASDAQ), SIENTRA INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), CYTOSORBENTS CORP (NASDAQ), CUTERA INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ELECTROCORE INC (NASDAQ), PW MEDTECH (HKEx), AVEDRO INC (NASDAQ), NUVECTRA CORPORATION (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), CRH MEDICAL CORP (NYSE American), INFUSYSTEM HOLDINGS INC (NYSE American), MISONIX INC (NASDAQ), INTRICOM CORP (NASDAQ), BIOTIME INC (NYSE American), CONFORMIS INC (NASDAQ), MODERN DENTAL (HKEx), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), EKSO BIONICS HOLDINGS INC (NASDAQ), FONAR CORP (NASDAQ), ZYNEX INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ONCOCYTE CORP (NYSE American), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), SOLITON INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), CORMEDIX INC (NYSE American), YUNNAN ENERGY (HKEx), SOMNOMED LIMITED (ASX), MOTUS GI HOLDINGS INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), ENDOLOGIX INC (NASDAQ), SDI LTD (ASX), CAS MEDICAL SYSTEMS (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), ELLEX MEDICAL LASERS LTD (ASX), IMPEDIMED LIMITED (ASX), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), VINCENT MED (HKEx), IRIDEX CORP (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), CYCLOPHARM LIMITED (ASX), NEUROTROPE INC (NASDAQ), ALPHA PRO TECH (NYSE American), BIOLASE INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), BELLEROPHON THERAPEUTICS INC (NASDAQ), DAXOR CORP (NYSE American), VIVEVE MEDICAL INC (NASDAQ), ELECTROMED INC (NYSE American), TITAN MEDICAL INC (NASDAQ), COMPUMEDICS (ASX), LIFE HEALTHCARE (HKEx), CELSION CORPORATION (NASDAQ), AVINGER INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), IMMUCELL CORP (NASDAQ), VALERITAS HOLDINGS INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), PAVMED INC (NASDAQ), RESTORATION ROBOTICS INC (NASDAQ), MICRO-X LTD (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), RESPIRI LTD (ASX), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), DARIOHEALTH CORP (NASDAQ), BIOMERICA INC (NASDAQ), NEOVASC INC (NASDAQ), OBJ LIMITED (ASX), RESONANCE HEALTH LTD (ASX), ATOSSA GENETICS INC (NASDAQ), DIGIRAD CORP (NASDAQ), OVENTUS MEDICAL LTD (ASX), REALM THERAPEUTICS PLC SPONSORED ADS (NASDAQ), CYANOTECH CORP (NASDAQ), CARDIEX LTD (ASX), AETHLON MEDICAL (NASDAQ), DYNATRONICS CORP (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), USCOM LTD (ASX), HUAKANG BIOMED (HKEx), EMVISION MEDICAL DEVICES LTD (ASX), PRESBIA PLC (NASDAQ), COMBEST HOLD (HKEx), ADMEDUS LTD (ASX), CHECK-CAP LTD (NASDAQ), OPTISCAN IMAGING (ASX), AKERS BIOSCIENCES INC (NASDAQ), ADVENTA (Bursa), MILESTONE SCIENTIFIC INC (NYSE American), PRECISION THERAPEUTICS INC (NASDAQ), LKL (Bursa), DIMERIX LTD (ASX), ANALYTICA (ASX), IMPRESSION HEALTHCARE LIMITED (ASX), NEUROMETRIX INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), LBT INNOVATIONS LTD (ASX), MICRON SOLUTIONS INC (NYSE American), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), CESCA THERAPEUTICS INC (NASDAQ), CH DEMETER FIN (HKEx), SINTX TECHNOLOGIES INC (NASDAQ), METALICITY LIMITED (ASX), CHF SOLUTIONS INC (NASDAQ), ADHERIUM LIMITED (ASX), TENAX THERAPEUTICS INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), MEDIGARD LIMITED (ASX), INSPIREMD INC (NYSE American), MY MEDICARE (HKEx), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.030
-10.71 %
10 Days --0.030
-10.71 %
20 Days --0.025
-9.09 %
Medium Term Return 3 Months -+0.045
+21.95 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.180 - 0.330 Change From 1 Year Low +0.070 % Change From 1 Year Low (%) +38.89
Change From 1 Year High -0.080 % Change From 1 Year High (%) -24.24
2 Years Range 0.180 - 0.330 Change From 2 Years Low +0.070 % Change From 2 Years Low (%) +38.89
Change From 2 Years High -0.080 % Change From 2 Years High (%) -24.24
5 Years Range 0.180 - 0.330 Change From 5 Years Low +0.070 % Change From 5 Years Low (%) +38.89
Change From 5 Years High -0.080 % Change From 5 Years High (%) -24.24
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company is a Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. The Company aspires to impact the lives of patients through the provision of diagnostic solutions in every cancer centre worldwide. The Company has developed the ClearCell FX1 System, a fully automated IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patients body.

IPO Performance

Listing Date 19 Dec 2018 Full Subscription Rate (x) -
No of Placement Shares (M) 27.50 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.235 First Week Close (SGD) 0.230
Current vs IPO Price (%) -10.71 First Day Gain (%) -16.07 First Week Gain (%) -17.86

Reports Download

Report Type Financial Year Ended Download
IPO Prospectus
IPO Prospectus 2018 Dec 2018 Part 1(2.88 MB)
Part 2(0.53 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
21 Mar 2019 0.255 0.255 0.250 0.250 108,000 0.2546
20 Mar 2019 0.260 0.265 0.250 0.265 95,200 0.2550
19 Mar 2019 0.260 0.270 0.260 0.270 40,000 0.2660
18 Mar 2019 0.260 0.280 0.260 0.280 106,600 0.2601
15 Mar 2019 0.260 0.280 0.260 0.280 52,000 0.2634
14 Mar 2019 0.285 0.285 0.270 0.280 101,000 0.2774
13 Mar 2019 0.270 0.275 0.265 0.270 231,700 0.2719
12 Mar 2019 0.275 0.280 0.250 0.265 124,800 0.2565
11 Mar 2019 0.270 0.275 0.270 0.275 10,700 0.2703
08 Mar 2019 0.260 0.290 0.260 0.285 464,000 0.2788
07 Mar 2019 0.270 0.280 0.270 0.280 138,000 0.2758
06 Mar 2019 0.255 0.290 0.255 0.290 28,500 0.2556
05 Mar 2019 0.265 0.280 0.265 0.280 30,400 0.2669
04 Mar 2019 0.260 0.290 0.260 0.290 226,000 0.2641
01 Mar 2019 0.275 0.280 0.260 0.280 149,700 0.2650
28 Feb 2019 0.255 0.275 0.255 0.275 308,000 0.2571
27 Feb 2019 0.245 0.275 0.245 0.270 138,600 0.2621
26 Feb 2019 0.250 0.260 0.240 0.260 116,600 0.2464
25 Feb 2019 0.275 0.275 0.250 0.260 393,900 0.2618
22 Feb 2019 0.275 0.285 0.255 0.275 310,500 0.2615
21 Feb 2019 0.300 0.300 0.275 0.275 852,300 0.2887
20 Feb 2019 0.300 0.300 0.290 0.300 387,900 0.2944
Summary
Current 2 Weeks
(08 Mar 2019 to 21 Mar 2019)
0.260 0.290 0.250 0.250 1,334,000 -
Previous 2 Weeks
(22 Feb 2019 to 07 Mar 2019)
0.275 0.290 0.250 0.280 1,840,200 -
4 Weeks from
(23 Jan 2019 to 21 Feb 2019)
0.210 0.290 0.210 0.275 6,274,800 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.